GSK globalt har nå lansert Global Health Africa Open Lab

GSK globalt har nå lansert "Global Health Africa Open Lab”, hvor de inviterer forskere basert i Afrika til å søke om forskningsstøtte/utviklingsprogram med fokus på infeksjonssykdommer.

Infectious diseases (IDs) such as malaria, tuberculosis (TB) and enteric diseases are among the leading causes of death globally, killing almost 9 million people each year. These diseases, which are often preventable and treatable, disproportionately affect sub-Sahara African (SSA) populations, causing significant morbidity and mortality. Research is critical for the development and implementation of effective measures to meet the global health challenges of eliminating IDs.

Having previously funded 20 projects through the Africa NCD Open Lab, we are now calling for research proposals focused on funding high-quality infectious disease research that has the potential to deliver significant health impact and develop future research leaders, with up to £75,000 available per award. Along with the award we offer mentoring, scientific and technical support while you conduct your innovative research project.

The deadline for applications is 17 February 2023.

Read more about the call: Africa Open Lab